Related Experiment Videos
Metered dose inhalers and spacer devices
1Department of Cardiovascular and Respiratory Sciences, University La Sapienza, Rome, Italy.
European Review for Medical and Pharmacological Sciences
|November 10, 2000
Summary
Metered dose inhalers are widely used for accurate drug delivery. This review covers inhaler technique, add-on devices, and new propellant technologies for optimal clinical response.
Area of Science:
- Pulmonary medicine
- Pharmaceutical technology
Background:
- Metered dose inhalers (MDIs) are the most common globally utilized inhalation devices due to their ease of use, efficacy, safety, and consistent dosing.
- Patient's clinical response can be significantly influenced by their inhalation technique and the specific formulation within the MDI canister.
Purpose of the Study:
- To review metered dose inhalers (MDIs), associated add-on devices, and the importance of patient training for coordinated drug delivery.
- To discuss advancements in MDI technology, focusing on the development and study of non-ozone depleting propellants in adherence to the Montreal Protocol.
Main Methods:
- Literature review of clinical studies and technological advancements related to metered dose inhalers.
- Analysis of factors affecting MDI efficacy, including inhalation technique and device formulation.
- Examination of research on environmentally friendly propellants for MDI applications.
Main Results:
- Proper inhalation technique and device selection are crucial for optimal therapeutic outcomes with MDIs.
- New propellant technologies are being developed to comply with environmental regulations like the Montreal Protocol.
- Add-on devices and targeted training can improve MDI use and patient adherence.
Conclusions:
- Optimizing metered dose inhaler (MDI) therapy requires a comprehensive approach, addressing device technology, formulation, and patient technique.
- The transition to environmentally safe propellants is essential for the continued use of MDIs.
- Further research and education are needed to maximize the benefits of MDIs for patients with respiratory conditions.